Gene · 406909
Papers2,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum exosomal microRNA profiling reveals a down-regulation of hsa-miR-124-3p in patients with severe acne. | Front Immunol | 2025 | 40625748 | PubTator, text mining | PubMed |
| Upregulation of circRNA_0002286 protects against brain ischemia/reperfusion injury after remote ischemic postconditioning via microRNA-124-3p/VLCAD axis. | J Mol Histol | 2025 | 40615768 | PubTator, text mining | PubMed |
| Comprehensive analysis of pyroptosis-related gene signatures in renal fibrosis. | Clin Exp Nephrol | 2025 | 40608262 | PubTator, text mining | PubMed |
| Differentially expressed microRNAs in human depression: a systematic review of case-control and longitudinal studies. | BMC Psychiatry | 2025 | 40598020 | PubTator, text mining | PubMed |
| Screening and evaluation of specific blood MiRNAs as potential biomarkers in diagnostics of gastric Cancer. | Sci Rep | 2025 | 40594436 | PubTator, text mining | PubMed |
| SLC7A1, SGK1 and HMGB2 are overexpressed in cervical cancer tissues and the miR‑23b‑3p/HMGB2 axis regulates cell migration and invasion. | Mol Med Rep | 2025 | 40576131 | PubTator, text mining | PubMed |
| In silico analysis of nicotine's molecular targets in Parkinson's disease. | Xenobiotica | 2025 | 40533911 | PubTator, text mining | PubMed |
| EZH2: A Crucial Competing Endogenous RNA in Cancer Research-A Scoping Review. | Adv Biomed Res | 2025 | 40519579 | PubTator, text mining | PubMed |
| The Role of miR-124-3p/UHRF1 in NaAsO2-Induced Apoptosis of LX-2 Cells via DNMT1/SOCS1. | J Appl Toxicol | 2025 | 40509639 | PubTator, text mining | PubMed |
| Application of microRNA In Situ Hybridization on Long-term Stored Human Formalin-fixed Paraffin-embedded Brain Samples from Psychiatric Patients. | Mol Neurobiol | 2025 | 40450086 | PubTator, text mining | PubMed |
| Longitudinal analysis of hsa-miR-3163, hsa-miR-124-3p, hsa-miR-548c-3p, and hsa-miR-27a-3p as prognostic biomarkers in HIV-infected patients. | Front Immunol | 2025 | 40396180 | PubTator, text mining | PubMed |
| MiR-124-3p inhibits proliferation, migration, and epithelial-mesenchymal transformation in gastric cancer by targeting ITGB1. | Am J Transl Res | 2025 | 40385048 | PubTator, text mining | PubMed |
| Progress of arylacetamide deacetylase research in metabolic diseases. | Front Oncol | 2025 | 40376582 | PubTator, text mining | PubMed |
| Methylation-Mediated Silencing of miR-124-3 Regulates LRRC1 Expression and Promotes Oral Cancer Progression. | Cancers (Basel) | 2025 | 40227650 | PubTator, text mining | PubMed |
| Ambrisentan Retains Its Pro-Autophagic Activity on Human Pulmonary Artery Endothelial Cells Exposed to Hypoxia in an In Vitro Model Mimicking Diabetes. | J Cell Mol Med | 2025 | 40205749 | PubTator, text mining | PubMed |
| Exosomes enriched with miR-124-3p show therapeutic potential in a new microfluidic triculture model that recapitulates neuron-glia crosstalk in Alzheimer's disease. | Front Pharmacol | 2025 | 40144670 | PubTator, text mining | PubMed |
| Exploring common genomic biomarkers to disclose common drugs for the treatment of colorectal cancer and hepatocellular carcinoma with type-2 diabetes through transcriptomics analysis. | PLoS One | 2025 | 40127075 | PubTator, text mining | PubMed |
| miR-124-mediated temozolomide sensitivity and DNA repair modulation in Glioblastoma Multiforme. | Neuroscience | 2025 | 40064365 | PubTator, text mining | PubMed |
| The dual role of circHIPK3 in cancer and its implications for multiple drugs resistance: a systematic review and computational approach. | Front Oncol | 2025 | 40061896 | PubTator, text mining | PubMed |
| Plasma exosomal miRNA expression and gut microbiota dysbiosis are associated with cognitive impairment in Alzheimer's disease. | Front Neurosci | 2025 | 40046438 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406909/papers?page=6